Holen Sie sich die Stockscreener-App
221.96
2.72%
-6.43
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt LRCX?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$228.39
Offen:
$235.56
24-Stunden-Volumen:
5.19M
Relative Volume:
0.47
Marktkapitalisierung:
$278.80B
Einnahmen:
$19.59B
Nettoeinkommen (Verlust:
$5.81B
KGV:
48.91
EPS:
4.538
Netto-Cashflow:
$5.55B
1W Leistung:
+2.17%
1M Leistung:
+26.77%
6M Leistung:
+127.43%
1J Leistung:
+166.88%
1-Tages-Spanne:
$219.76
$236.10
1-Wochen-Bereich:
$217.61
$236.10
52-Wochen-Spanne:
$56.32
$236.10
Lam Research Corp Stock (LRCX) Company Profile
Firmenname
Lam Research Corp
Sektor
Telefon
(510) 659-0200
Adresse
4650 CUSHING BLVD, FREMONT, CA
Vergleichen Sie LRCX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LRCX
Lam Research Corp
|
221.97 | 286.86B | 19.59B | 5.81B | 5.55B | 4.538 |
|
ASML
Asml Holding Nv
|
1,379.06 | 527.92B | 35.54B | 10.43B | 9.71B | 26.71 |
|
AMAT
Applied Materials Inc
|
321.74 | 257.90B | 28.37B | 7.00B | 5.70B | 8.6741 |
|
KLAC
Kla Corp
|
1,517.32 | 199.72B | 12.52B | 4.24B | 3.87B | 31.85 |
|
TER
Teradyne Inc
|
230.21 | 36.32B | 2.86B | 443.08M | 456.83M | 2.7476 |
Lam Research Corp Stock (LRCX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-15 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2026-01-15 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2025-10-23 | Bestätigt | TD Cowen | Buy |
| 2025-09-30 | Eingeleitet | HSBC Securities | Hold |
| 2025-09-29 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2025-09-23 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2025-09-22 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2025-09-02 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2025-08-14 | Fortgesetzt | Erste Group | Buy |
| 2025-07-31 | Herabstufung | Summit Insights | Buy → Hold |
| 2025-07-31 | Bestätigt | TD Cowen | Buy |
| 2025-07-10 | Eingeleitet | Goldman | Buy |
| 2025-04-24 | Bestätigt | TD Cowen | Buy |
| 2025-03-20 | Fortgesetzt | Oppenheimer | Outperform |
| 2025-02-20 | Hochstufung | Susquehanna | Neutral → Positive |
| 2025-01-30 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2025-01-30 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2025-01-17 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-01-15 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2024-12-17 | Eingeleitet | Cleveland Research | Neutral |
| 2024-08-01 | Bestätigt | TD Cowen | Buy |
| 2024-05-13 | Eingeleitet | Jefferies | Buy |
| 2024-04-25 | Bestätigt | TD Cowen | Buy |
| 2024-04-19 | Hochstufung | B. Riley Securities | Neutral → Buy |
| 2024-04-18 | Bestätigt | Needham | Buy |
| 2024-04-16 | Eingeleitet | Evercore ISI | Outperform |
| 2024-04-11 | Fortgesetzt | Deutsche Bank | Hold |
| 2024-01-25 | Bestätigt | TD Cowen | Outperform |
| 2024-01-23 | Eingeleitet | Cantor Fitzgerald | Neutral |
| 2023-12-12 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2023-12-08 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2023-11-22 | Eingeleitet | Redburn Atlantic | Buy |
| 2023-10-17 | Eingeleitet | Raymond James | Outperform |
| 2023-10-13 | Hochstufung | Needham | Hold → Buy |
| 2023-09-15 | Eingeleitet | Wolfe Research | Outperform |
| 2023-07-24 | Bestätigt | Mizuho | Buy |
| 2023-07-24 | Hochstufung | Stifel | Hold → Buy |
| 2023-04-20 | Bestätigt | Berenberg | Buy |
| 2023-04-20 | Bestätigt | Evercore ISI | Outperform |
| 2023-04-20 | Bestätigt | JP Morgan | Overweight |
| 2023-04-20 | Bestätigt | Jefferies | Buy |
| 2023-04-20 | Bestätigt | Mizuho | Buy |
| 2023-04-20 | Bestätigt | Stifel | Hold |
| 2023-04-20 | Bestätigt | Wells Fargo | Equal Weight |
| 2023-03-13 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2023-01-18 | Fortgesetzt | Stifel | Hold |
| 2022-12-12 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2022-10-20 | Bestätigt | B. Riley Securities | Neutral |
| 2022-10-20 | Bestätigt | BofA Securities | Buy |
| 2022-10-20 | Bestätigt | DA Davidson | Neutral |
| 2022-10-20 | Bestätigt | Evercore ISI | Outperform |
| 2022-10-20 | Bestätigt | JP Morgan | Overweight |
| 2022-10-20 | Bestätigt | Jefferies | Buy |
| 2022-10-20 | Hochstufung | Summit Insights | Hold → Buy |
| 2022-10-20 | Bestätigt | Wells Fargo | Equal Weight |
| 2022-07-25 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2022-06-15 | Herabstufung | B. Riley Securities | Buy → Neutral |
| 2022-01-27 | Bestätigt | Barclays | Overweight |
| 2022-01-27 | Bestätigt | Deutsche Bank | Hold |
| 2022-01-27 | Bestätigt | Evercore ISI | Outperform |
| 2022-01-27 | Bestätigt | Stifel | Buy |
| 2022-01-27 | Bestätigt | Susquehanna | Neutral |
| 2022-01-27 | Bestätigt | UBS | Buy |
| 2022-01-26 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2022-01-12 | Bestätigt | Barclays | Overweight |
| 2022-01-10 | Bestätigt | BofA Securities | Buy |
| 2022-01-05 | Fortgesetzt | Jefferies | Buy |
| 2021-12-15 | Bestätigt | Deutsche Bank | Hold |
| 2021-10-21 | Bestätigt | B. Riley Securities | Buy |
| 2021-10-21 | Herabstufung | Summit Insights | Buy → Hold |
| 2021-10-15 | Eingeleitet | Piper Sandler | Neutral |
| 2021-09-14 | Herabstufung | Susquehanna | Positive → Neutral |
| 2021-09-07 | Herabstufung | Exane BNP Paribas | Outperform → Neutral |
| 2021-07-29 | Bestätigt | Mizuho | Buy |
| 2021-07-29 | Bestätigt | Stifel | Buy |
| 2021-07-29 | Bestätigt | UBS | Buy |
| 2021-07-29 | Bestätigt | Wells Fargo | Equal Weight |
| 2021-03-31 | Eingeleitet | Bernstein | Outperform |
| 2021-01-28 | Bestätigt | Cowen | Outperform |
| 2021-01-08 | Herabstufung | Needham | Buy → Hold |
| 2020-12-17 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2020-10-22 | Bestätigt | Goldman | Buy |
| 2020-10-22 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2020-10-22 | Bestätigt | Mizuho | Buy |
| 2020-10-22 | Bestätigt | Morgan Stanley | Overweight |
| 2020-10-22 | Bestätigt | RBC Capital Mkts | Outperform |
| 2020-10-22 | Bestätigt | Stifel | Buy |
| 2020-10-22 | Bestätigt | UBS | Buy |
| 2020-09-21 | Hochstufung | Stifel | Hold → Buy |
| 2020-07-30 | Bestätigt | Cowen | Outperform |
| 2020-07-21 | Hochstufung | B. Riley FBR | Neutral → Buy |
| 2020-06-22 | Herabstufung | Stifel | Buy → Hold |
| 2020-06-16 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2020-05-26 | Eingeleitet | Barclays | Overweight |
| 2020-04-23 | Bestätigt | Needham | Buy |
| 2020-04-08 | Eingeleitet | Exane BNP Paribas | Outperform |
| 2020-04-03 | Hochstufung | Nomura | Neutral → Buy |
| 2020-04-02 | Herabstufung | DA Davidson | Buy → Neutral |
| 2020-03-27 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2020-03-27 | Hochstufung | UBS | Sell → Buy |
Alle ansehen
Lam Research Corp Aktie (LRCX) Neueste Nachrichten
Lam Research (LRCX) Sees Price Target Increase Amid Wafer Equipm - GuruFocus
Simplicity Wealth LLC Sells 32,151 Shares of Lam Research Corporation $LRCX - MarketBeat
Jim Cramer Calls Lam Research the "Best of the Best" But Warns Against Buying Parabolic Moves - Finviz
Jim Cramer Calls Lam Research the “Best of the Best” But Warns Against Buying Parabolic Moves - Insider Monkey
Lam Research (NASDAQ:LRCX) Stock Price Up 2.7%Still a Buy? - MarketBeat
Lam Research stock climbs as Deutsche Bank lifts target ahead of Jan. 28 earnings - TechStock²
Lam Research Corp stock hits all-time high of 229.58 USD - Investing.com Nigeria
Lam Research Corp stock hits all-time high of 229.58 USD By Investing.com - Investing.com India
Wealth Enhancement Advisory Services LLC Sells 20,578 Shares of Lam Research Corporation $LRCX - MarketBeat
Lam Research To Rally Around 17%? Here Are 10 Top Analyst Forecasts For Wednesday - Benzinga
Lam Research in focus as Deutsche Bank ups target ahead of earnings (LRCX:NASDAQ) - Seeking Alpha
Lam Research Corporation $LRCX Shares Bought by Vest Financial LLC - MarketBeat
Analyst recommendations: Fedex, Netflix, Albemarle, Lam Research… - marketscreener.com
Lam Research stock swings on tariff jitters as UBS lifts target ahead of earnings - TechStock²
Scott & Selber Inc. Invests $6.37 Million in Lam Research Corporation $LRCX - MarketBeat
Lam Research Corporation $LRCX Position Boosted by Inscription Capital LLC - MarketBeat
Birinyi Associates Inc Invests $937,000 in Lam Research Corporation $LRCX - MarketBeat
Arkadios Wealth Advisors Raises Holdings in Lam Research Corporation $LRCX - MarketBeat
Mizuho Markets Americas LLC Buys New Stake in Lam Research Corporation $LRCX - MarketBeat
Quantum Portfolio Management LLC Has $1.79 Million Position in Lam Research Corporation $LRCX - MarketBeat
Massachusetts Financial Services Co. MA Buys 363,801 Shares of Lam Research Corporation $LRCX - MarketBeat
Lam Research Corporation $LRCX Shares Purchased by Sequoia Financial Advisors LLC - MarketBeat
Lam Research Corporation $LRCX Shares Sold by Harel Insurance Investments & Financial Services Ltd. - MarketBeat
Lam Research Corporation $LRCX Shares Bought by Allstate Corp - MarketBeat
Nippon Life Global Investors Americas Inc. Purchases 9,190 Shares of Lam Research Corporation $LRCX - MarketBeat
20,267 Shares in Lam Research Corporation $LRCX Purchased by Donoghue Forlines LLC - MarketBeat
Sen. Markwayne Mullin Buys Lam Research Corporation (NASDAQ:LRCX) Stock - MarketBeat
Lam Research Corporation (LRCX) Price Target Raised to $220 Amid Rising Semiconductor Investments - Intellectia AI
Analysts Bullish on Lam Research Corporation (LRCX) as Semiconductor Capex and Memory Investments Rise - Insider Monkey
Wilmington Savings Fund Society FSB Has $4.70 Million Stock Position in Lam Research Corporation $LRCX - MarketBeat
QRG Capital Management Inc. Decreases Stake in Lam Research Corporation $LRCX - MarketBeat
Lam Research Corporation $LRCX Shares Sold by Nwam LLC - MarketBeat
Lam Research (NASDAQ:LRCX) Trading Up 2.5% After Analyst Upgrade - MarketBeat
Lam Research Unusual Options ActivityLam Research (NASDAQ:LRCX) - Benzinga
Analysts Upgrade Zscaler and Lam Research Ratings, Positive Outlook - Intellectia AI
Wright Investors Service Inc. Invests $1.85 Million in Lam Research Corporation $LRCX - MarketBeat
Here's How Much You'd Have If You Invested $1000 in Lam Research a Decade Ago - Yahoo Finance
Lam Research (NASDAQ:LRCX) Upgraded at Wells Fargo & Company - MarketBeat
Lam Research Corporation $LRCX Shares Acquired by Stephens Inc. AR - MarketBeat
Fjarde AP Fonden Fourth Swedish National Pension Fund Has $48.19 Million Holdings in Lam Research Corporation $LRCX - MarketBeat
What to expect from Lam Research’s Q2 2025 earnings report - MSN
Lam Research (NASDAQ:LRCX) Given New $225.00 Price Target at Rothschild & Co Redburn - MarketBeat
KLA, ASML, Lam Research, Applied Materials Surge as Chip Stocks Get a Boost - Barron's
Lam Research (NASDAQ:LRCX) Shares Up 4.2% on Analyst Upgrade - MarketBeat
Lobbying Update: $60,000 of LAM RESEARCH CORPORATION lobbying was just disclosed - Quiver Quantitative
Why Lam Research (LRCX) Stock Is Trading Up Today - Finviz
Lam Research (LRCX) Surges 6% on Positive Wafer Equipment Outloo - GuruFocus
Lam Research Corp. (LRCX) Receives Bullish Upgrades with Price Targets Up to $260 - Intellectia AI
TSMC Earnings Reset the AI Narrative After Rotation Fears Hit Tech Stocks - Investing.com
Is Lam Research (LRCX) a Buy as Wall Street Analysts Look Optimistic? - Finviz
B. Riley Adjusts Price Target on Lam Research to $255 From $195, Maintains Buy Rating - marketscreener.com
Finanzdaten der Lam Research Corp-Aktie (LRCX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Lam Research Corp-Aktie (LRCX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| ARCHER TIMOTHY | President and CEO |
Dec 17 '25 |
Sale |
163.86 |
163,300 |
26,758,338 |
932,409 |
1.00%
1.59%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):